Updated:
In'Tech Medical
Founded in 2000 by Laurent Pruvost in Wimereux, France, In'Tech Medical began as a precision subcontractor for the local orthopedic cluster. The company...
In'Tech Medical
Founded in 2000 by Laurent Pruvost in Wimereux, France, In'Tech Medical began as a precision subcontractor for the local orthopedic cluster. The company transitioned from component supplier to full-service outsourcing partner, now designing and manufacturing complete surgical instrument sets, implants, and sterile-packed procedure kits for the global orthopedics market. In'Tech Medical's production scope spans titanium and cobalt-chrome implant machining, 3D-printed porous structures, polymer processing, and cleanroom assembly and sterilization. The firm's core demand driver is the aging global population's hip and knee reconstruction volume. Key clients include Stryker, Zimmer Biomet, Smith & Nephew, and DePuy Synthes — relationships disclosed in supplier registries and quality certifications. Manufacturing spans three facilities in France (Wimereux, Rang-du-Fliers, and La Rochelle) and two in the United States (Memphis, TN and Lancaster, SC), creating a localized supply chain for the two largest orthopedic markets. Since 2018, In'Tech Medical has executed six acquisitions, absorbing U.S.-based Backes Orthopaedics, MedTech Surgical, and New England Precision Grinding. The firm entered the transcatheter structural heart space through specialist micro-component machining for valve delivery systems. In May 2022, French private equity firm Andera Partners and government fund Bpifrance acquired a majority stake, valuing the business at approximately €400 million. The deal recapitalized the company while leaving Pruvost as President and significant minority shareholder. In'Tech Medical's structural differentiator is its status as the last scaled independent supplier in a consolidating orthopedic supply chain. While larger CMOs like Jabil and Flex enter medical device assembly, In'Tech remains sole-specialist in the tight-tolerance metalwork and instrument sterilization that OEMs outsource most cautiously — a moat built on 134,000 square meters of FDA-registered manufacturing space and ISO 13485 certifications that take competitors a decade to replicate.
General information
Firm type
Asset Manager
Year founded
2000
AUM
Undisclosed
Location
Region
Europe
Country
France
City
Wimereux
Corporate office
Wimereux, France
Additional offices
Memphis, TN, United States · Lancaster, SC, United States
Principals
Laurent Pruvost
President & CEO
Sector focus
Frequently asked questions
Who runs In'Tech Medical and how is it owned?
Laurent Pruvost founded the company in 2000 and serves as President and CEO. Since May 2022, French private equity firm Andera Partners and state-backed Bpifrance have held a majority stake, with Pruvost and management retaining significant minority equity.
What is In'Tech Medical's core business?
The company is a contract manufacturer specializing in orthopedic implants, surgical instruments, and sterile-packed medical kits. It produces titanium and cobalt-chrome components, 3D-printed porous implants, and fully assembled procedure trays for the world's largest orthopedic OEMs.
What manufacturing capabilities does In'Tech Medical operate?
In'Tech runs five production sites: three in France (Wimereux, Rang-du-Fliers, La Rochelle) and two in the United States (Memphis, TN and Lancaster, SC). Capabilities include CNC machining, additive manufacturing, polymer injection molding, and full cleanroom assembly and sterilization.
Who are In'Tech Medical's primary customers?
Its disclosed and inferred customer base includes Stryker, Zimmer Biomet, DePuy Synthes, and Smith & Nephew — the four dominant global orthopedic OEMs. The firm is a tier-one supplier for complex instrument sets and implant subcomponents.
How does In'Tech Medical source deals for its acquisition strategy?
The firm targets specialized contract manufacturers in the United States and Europe with complementary precision machining capabilities. Acquisitions since 2018 include Backes Orthopaedics, MedTech Surgical, and New England Precision Grinding — each adding niche metal-finishing or instrument-assembly capacity.
Does In'Tech Medical participate in fund commitments or only direct investments?
In'Tech Medical is an operating company, not an investment fund. Its capital deployment takes the form of direct acquisitions of manufacturing businesses that expand its capabilities or geographic reach.
What is In'Tech Medical's known posture on sterile packaging and regulatory compliance?
The company maintains ISO 13485 quality management certification across its sites and holds FDA registration for its U.S. facilities. It offers terminal sterilization and cleanroom packaging, allowing OEM customers to receive fully finished, implantable products direct from the contract manufacturer.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: